Picture of Lakefront Biotherapeutics NV logo

LKFT Lakefront Biotherapeutics NV News Story

0.000.00%
nl flag iconLast trade - 00:00
HealthcareBalancedMid CapSuper Stock

Brief: Galapagos Announces Strategic Update On Proposed Separation, Leadership Transition, Board Changes

May 13 (Reuters) - Galapagos NV GLPG.AS:

GALAPAGOS ANNOUNCES STRATEGIC UPDATE ON PROPOSED SEPARATION, EXECUTIVE LEADERSHIP TRANSITION AND BOARD CHANGES

TO EXPLORE STRATEGIC ALTERNATIVES FOR EXISTING BUSINESSES

TO RE-EVALUATE SEPARATION PLAN DUE TO MARKET DEVELOPMENTS

HENRY GOSEBRUCH APPOINTED AS CEO OF GALAPAGOS

PAUL STOFFELS TO REMAIN AS ADVISOR FOR GALAPAGOS

JÉRÔME CONTAMINE APPOINTED AS CHAIR OF GALAPAGOS BOARD

Source text: ID:nGNX7Xg1bF

Further company coverage: GLPG.AS

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Lakefront Biotherapeutics NV

See all news